Managing the continuum of treatment: modeling the economic impact of treating diabetes.
To describe economic models that may be useful for assessing the long-term and short-term cost-effectiveness of treatment options in the management of type 2 diabetes. Because clinical studies typically focus on short-term efficacy and safety, evaluating the long-term cost-effectiveness of various treatment options in the management of type 2 diabetes remains daunting. Long-term cost-modeling approaches offer an option for estimating the true costs of type 2 diabetes, which necessarily include the cost impact of complications, and suggest that tight glycemic control is a cost-effective step in reducing the risks for costly cardiovascular and renal complications. Short-term cost models can facilitate the evaluation of the cost-effectiveness of different drug regimens used to manage type 2 diabetes, an important step in formulary decision making. In the absence of long-term, prospective studies to assess cost-effectiveness, cost modeling may be a useful tool in assessing the full economic impact of diabetes-related complications and the cost benefits that can be realized by managed care organizations that implement treatment approaches to avert these complications.